Not finding it? Sign in to also search OpenAlex live.
-
Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress2024 Research and Practice in Thrombosis and Haemostasis article Medicine Blood Coagulation and Thrombosis Mechanisms Open access
Nicola S. Curry, Kerstin Jurk, Henri H. Versteeg, Charithani Bhagya Keragala, Tal Burstyn-Cohen, Silvio Antoniak, +22 more
5citations -
PB0121 Relationship of Thrombo-Inflammatory Biomarkers with Oxidative Stress Level in Non-Small Cell Lung Cancer Patients2023 Research and Practice in Thrombosis and Haemostasis conference-abstract Medicine Blood Coagulation and Thrombosis Mechanisms Open access
Srdjan S. Nikolovski, Mark Jaradeh, Jeanine M. Walenga, D. Hoppensteadt, Bülent Kantarcıoğlu, Jawed Fareed, +1 more
1citations -
Biological clocks and blood clots in space: circadian disruption-induced modulation of thrombosis risk2026 Research and Practice in Thrombosis and Haemostasis review Medicine Spaceflight effects on biology Open access
Ronan P. Murphy, Germaine Cornélissen, David Andrew Green, Roopen Arya, Suzanne C. Cannegieter, Nandu Goswami
0citations -
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex2022 Journal of Innate Immunity article Immunology and Microbiology Complement system in diseases Open access
Heidi Gytz Olesen, Iliana Michailidou, Wioleta Milena Zelek, Jeroen P. Vreijling, Patrick Ruizendaal, Ferry de Klein, +11 more
14citations -
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial2022 The Lancet Respiratory Medicine article Medicine COVID-19 Clinical Research Studies Open access cited by 2 patents
Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen, Leo M. A. Heunks, Bruno Mourvillier, Sanne de Bruin, +71 more
154citations -
Numerical stability and efficiency of response property calculations in density functional theory2023 Letters in Mathematical Physics article Physics and Astronomy Advanced Chemical Physics Studies Open access
Éric Cancès, Michael F. Herbst, Gaspard Kemlin, Antoine Levitt, Benjamin Stamm
6citations -
Recombinant Human C1 Esterase Inhibitor Treatment in Addition to Standard of Care for the Prevention of Cytokine Storm in Hospitalized Patients with COVID-19: A Randomized, Open-Label Trial
Bruno Giannetti, Jin P. Guo, Ashraf Raslan, Jürgen Schaale, Michael Bulitta, Anurag Relan, +1 more
0citations -
Comprehensive spatial profiling of the spleen in murine and human myelofibrosis identifies targetable immune-stromal interactions2025 Zenodo (CERN European Organization for Nuclear Research) dataset Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bérénice Dugué, Pia Wanner, Mayra L. Ruiz Tejada Segura, Charles Dussiau, Rebekka K. Schneider
0citations -
Comprehensive spatial profiling of the spleen in murine and human myelofibrosis identifies targetable immune-stromal interactions2025 Zenodo (CERN European Organization for Nuclear Research) dataset Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bérénice Dugué, Wanner Pia, Mayra L. Ruiz Tejada Segura, Charles Dussiau, Rebekka K. Schneider
0citations -
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies2021 Frontiers in Immunology article Immunology and Microbiology Complement system in diseases Open access
Markus A. Loeven, Marissa L. Maciej-Hulme, Cansu Yanginlar, Melanie C. Hubers, Edwin R. Kellenbach, Mark de Graaf, +5 more
21citations -
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells2022 European Journal of Immunology article Immunology and Microbiology Complement system in diseases Open access
Mieke F. van Essen, Nicole Schlagwein, Elisa M.P. van den Hoven, Daniëlle J. van Gijlswijk‐Janssen, Rosalie Lubbers, Ramon M. van den Bos, +4 more
8citations -
Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Caroline Irene Piatek, Jong Wook Lee, Morag Griffin, J Nishimura, Christopher Jordan Patriquin, Hubert Schrezenmeier, +9 more
2citations -
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies2022 American Journal of Nephrology article Immunology and Microbiology Complement system in diseases Open access
Carla Nester, Gerald B. Appel, Andrew S. Bomback, Koenraad Peter Bouman, H. Terence Cook, Erica Daina, +14 more
70citations -
The 2-year efficacy and safety of iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria with a history of aplastic anemia on concomitant immunosuppressive therapy who entered the roll-over extension program2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Anna Gayà, Morag Griffin, Bing Han, Austin Gladston Kulasekararaj, Jaroslaw Pawel Maciejewski, +11 more
0citations -
Management of recurrent C3 glomerulopathy after kidney transplantation2026 Nephrology Dialysis Transplantation article Immunology and Microbiology Complement system in diseases Open access
Hernando Trujillo, Teresa Cavero, Sarah Margaret Moran, Şafak Mirioğlu, Annette N. Bruchfeld, Stefanie Steiger, +7 more
0citations -
Plain Language Summary of PEGASUS, a Study Comparing Pegcetacoplan with Eculizumab for 16 Weeks in People with Paroxysmal Nocturnal Hemoglobinuria2023 Future Rare Diseases article Immunology and Microbiology Complement system in diseases Open access
Morag Griffin, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +11 more
0citations -
Thrombosis and Encapsulated Bacterial Infection Rates in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Pegcetacoplan: Nearly 3 Years of Post-Marketing Experience2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Gloria Frances Gerber, Richard Kelly, Hisakazu Nishimori, Regina Horneff, Peter Hillmen, Uchendu Orizu Uchendu, +2 more
1citations -
Plain language summary: treatment of paroxysmal nocturnal hemoglobinuria with pegcetacoplan for 48 weeks (PEGASUS study)2024 Future Rare Diseases article Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +10 more
0citations